In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...